0001493152-24-018884.txt : 20240513 0001493152-24-018884.hdr.sgml : 20240513 20240513161046 ACCESSION NUMBER: 0001493152-24-018884 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 15 CONFORMED PERIOD OF REPORT: 20240513 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240513 DATE AS OF CHANGE: 20240513 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ainos, Inc. CENTRAL INDEX KEY: 0001014763 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 751974352 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-41461 FILM NUMBER: 24939158 BUSINESS ADDRESS: STREET 1: AINOS, INC. STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 BUSINESS PHONE: 858-869-2986 MAIL ADDRESS: STREET 1: AINOS, INC. STREET 2: 8880 RIO SAN DIEGO DRIVE SUITE 800 CITY: SAN DIEGO STATE: CA ZIP: 92108 FORMER COMPANY: FORMER CONFORMED NAME: AMARILLO BIOSCIENCES INC DATE OF NAME CHANGE: 19960516 8-K 1 form8-k.htm
false 0001014763 0001014763 2024-05-13 2024-05-13 0001014763 AIMD:CommonStockParValue0.01PerShareMember 2024-05-13 2024-05-13 0001014763 AIMD:WarrantsToPurchaseCommonStockMember 2024-05-13 2024-05-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): May 13, 2024

 

 

 

AINOS, INC.
(Exact name of registrant as specified in its charter)

 

Texas   001-41461   75-1974352

(State or other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

8880 Rio San Diego Drive, Ste. 800, San Diego, CA 92108

(858) 869-2986

(Address and telephone number, including area code, of registrant’s principal executive offices)

 

(Former name or former address if changed since last report.)

 

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
     
  ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
     
  ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
     
  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.01 per share   AIMD   The Nasdaq Stock Market LLC
Warrants to purchase Common Stock   AIMDW   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 2.02. Results of Operations and Financial Condition.

 

On May 13, 2024, Ainos, Inc. (the “Company”) issued a press release announcing its financial results for the first quarter ended March 31, 2024. A copy of the press release is furnished herewith as Exhibit 99.1 and incorporated herein by reference.

 

The information in this Item 2.02 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, nor shall it be deemed incorporated by reference in any Company filing under the Securities Act of 1933 or the Securities Exchange Act of 1934, except as shall be expressly set forth by specific reference in such filing.

 

Item 9.01 Financial Statement and Exhibits

 

(d) Exhibits.

 

Exhibit No.   Description
99.1   Press Release dated May 13, 2024, issued by the Ainos, Inc.
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Ainos, Inc.
     
Date: May 13, 2024 By: /s/ Chun-Hsien Tsai
    Name: Chun-Hsien Tsai
    Title: Chief Executive Officer

 

 

 

 EX-99.1 2 ex99-1.htm

 

Exhibit 99.1

 

Ainos Reports First Quarter 2024 Financial Results

 

Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024

 

US$9M growth capital secured in May strengthens financial position for executing growth strategy

 

SAN DIEGO, May 13, 2024 /Accesswire/ — Ainos, Inc. (NASDAQ: AIMD, AIMDW) (“Ainos”, or the “Company”), a diversified healthcare company focused on the development of novel point-of-care testing (“POCT”), low-dose interferon therapeutics, and synthetic RNA-driven preventative medicine, today announced its financial results for the first quarter ended March 31, 2024.

 

Chun-Hsien (Eddy) Tsai, Chairman of the Board, President, and Chief Executive Officer of Ainos, commented, “In the first quarter, we successfully completed our strategic pivot away from COVID-19 rapid test kits, which contributed to the management of COVID-19 infections in Taiwan. While this adjustment impacted our near-term revenues, we’ve nonetheless made significant progress in diversifying our business for long-term sustainability. “

 

“Our strategic focus revolves around our AI Nose and VELDONA technologies. Specifically, we will intelligently advance our proprietary AI Nose technology platform-powered POCT candidate, Ainos Flora, and co-develop an innovative volatile organic compounds (“VOC”) sensing platform with our Japanese partners. The co-development program can expand the potential application of our AI-powered VOC sensing technology to telehealth, automotive, industrial, and environmental safety. Our first project aims to improve the quality of elderly care through an innovative AI-driven telehealth-based monitoring solution. We are also exploring to deploy VOC sensing to enable a safer work environment and better production quality in the high-tech factories.”

 

“In addition, we’re moving forward with clinical studies and actively exploring out-licensing opportunities for our VELDONA® human drug candidates. These include our promising candidate for treating oral warts in HIV-positive patients, which has received Orphan Drug Designation from the United States Food and Drug Administration (the “U.S. FDA”), and we plan to prioritize the HIV oral wart and Sjögren’s syndrome programs within our pipeline. Following our successful entry into the petcare market with VELDONA Pet supplement, we are investing to expand into the animal drug category.”

 

“I am confident that our long-term, diversified strategy positions us to deliver sustainable shareholder value. I am also profoundly grateful for the unwavering support from our shareholders. Their assistance was invaluable across multiple aspects, the engine that significantly drove us forward in both our clinical endeavors in Taiwan and collaboration in Japan. We look forward to our product making a swift and positive impact on people.”

 

Christopher Lee, Chief Financial Officer of Ainos, commented, “We have strengthened our financial position with two additional financings. I’m thrilled to share that we have secured a US$9 million convertible note financing convertible at US$4.5 per share, which follows an up to US$1.75 million financing we announced in January. These two financings bolster our position as we continue executing our growth strategy.”

 

 

 

 

First Quarter 2024 Financial Results

 

Revenues

 

Revenues were US$20,729 in the first quarter of 2024, compared to US$49,164 in the same period of 2023, reflecting the Company’s cessation of sales of its COVID-19 antigen rapid test kits during the first quarter of 2024 after a strategic pivot shift.

 

Cost of Revenues

 

Cost of revenues was US$26,754 in the first quarter of 2024, compared with U$100,848 in the same period of 2023. The decrease was primarily attributable to a decline in sales volume.

 

Gross Profit

 

In the first quarter of 2024, gross profit was negative US$6,025, significantly narrowing from negative US$51,684 a year ago, due to lower sales volumes of the Company’s newly launched products.

 

Total Operating Expenses

 

Total operating expenses were US$3,114,066 in the first quarter of 2024, compared to US$2,461,348 in the same period of 2023. The change was mainly attributable to increased expenses associated with clinical trial fees, co-research for technology, product and staffing expenditures, and increases in share-based compensation and professional expenses.

 

Operating expenses excluding depreciation and amortization expenses and share-based compensation were US$1,491,770 in the first quarter of 2024, compared to US$1,059,894 in the first quarter of 2023.

 

  ● R&D expenses increased to US$2,084,648 in the first quarter of 2024 from US$1,698,883 in the same period of 2023. Share-based compensation expenses and depreciation and amortization expenses in the first quarter of 2024 were US$1,284,343, compared with US$1,194,984 a year ago. When excluding these non-cash expenses, R&D expenses increased to US$800,305 from US$503,899 over the same period.
  ● SG&A expenses increased to US$1,029,418 from US$762,465 in the same period of 2023. Share-based compensation expenses and depreciation and amortization expenses in the first quarters of 2024 and 2023 were US$337,953 and US$206,470, respectively. When excluding these non-cash expenses, SG&A expenses increased to US$691,465 from US$555,995 over the same period.

 

Net Loss

 

Net loss attributable to common stock shareholders was US$3,314,810 in the first quarter of 2024, compared with US$2,520,475 in the same period of 2023.

 

Balance Sheet

 

As of March 31, 2024, the Company had cash and cash equivalents of US$1,030,899 compared with US$1,885,628 as of December 31, 2023.

 

 

 

 

Recent Business Developments

 

On May 6, 2024, the Company announced that it has raised US$9 million of growth capital through a convertible note financing with an existing shareholder. The three-year note carries 6% compound interest and is convertible Company’s common stock at US$4.50 per share. The investor will also receive a warrant to purchase up to 500,000 shares of the Company’s common stock at a price of US$4.50 per share.

 

On January 24, 2024, the Company announced that it had placed an additional financing of up to US$1.75 million. US$875,000 was funded at closing, with the remaining US$875,000 subject to conditions specified in the agreement.

 

On February 5, 2024, the Company announced that it had submitted the clinical hold complete response to the U.S. FDA for conducting a Phase II trial of its low-dose oral interferon (IFN)-alpha formulation, VELDONA®, for treatment of mild COVID-19 symptoms. If approved, the Company’s Phase II trial is expected to involve a multicenter, parallel, randomized study conducted in Taiwan to evaluate the efficacy of VELDONA® in subjects with mild COVID-19 symptoms during the third quarter of 2024.

 

About Ainos, Inc.

 

Headquartered in San Diego, California, Ainos is a diversified healthcare company focused on the development of novel point-of-care testing (POCT), low-dose VELDONA® interferon therapeutics, and synthetic RNA-driven preventative medicine. The company’s products include VELDONA® clinical-stage human therapeutics, VELDONA® Pet cytoprotein health supplements, and telehealth-friendly POCTs powered by its AI Nose technology platform. The lead POCT candidate, Ainos Flora, is intended to be a telehealth-friendly POCT for women’s health and certain common STIs. To learn more, visit https://www.ainos.com.

 

Follow Ainos on X, formerly known as Twitter, (@AinosInc) and LinkedIn to stay up-to-date.

 

Safe Harbor Statement

 

This press release contains “forward-looking statements” about Ainos within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements can be identified by the use of words such as “anticipate,” “believe,” “estimate,” “approximate,” “expect,” “intend,” “plan,” “predict,” “project,” “target,” “future,” “likely,” “strategy,” “foresee,” “may,” “guidance,” “potential,” “outlook,” “forecast,” “should,” “will” or other similar words or phrases. Similarly, statements that describe the Company’s objectives, plans or goals are, or may be, forward-looking statements. Forward-looking statements are based only on the Company’s current beliefs, expectations, and assumptions. Forward-looking statements are subject to inherent uncertainties, risks, and changes in circumstances that are difficult to predict and many of which are outside of the Company’s control. The Company’s actual results may differ materially from those indicated in the forward-looking statements.

 

 

 

 

Important factors that could cause the Company’s actual results to differ materially from the projections, forecasts, estimates and expectations discussed in this press release include, among others, the cost of production and sales potential of the products announced in this press release; the Company’s dependence on projected revenues from the sale of current or future products ; the Company’s limited cash and history of losses; the Company’s ability to achieve profitability; the Company’s ability to raise additional capital to continue the Company’s product development; the ability to accurately predict the future operating results of the Company; the ability to advance Ainos’ current or future product candidates through clinical trials, obtain marketing approval and ultimately commercialize any product candidates the Company develops; the ability to obtain and maintain regulatory approval of Ainos’ product candidates; delays in completing the development and commercialization of the Company’s current and future product candidates, which could result in increased costs to the Company, delay or limit the ability to generate revenue and adversely affect the business, financial condition, results of operations and prospects of the Company; intense competition and rapidly advancing technology in the Company’s industry that may outpace its technology; customer demand for the products and services the Company develops; the accuracy of third-party market research data, the impact of competitive or alternative products, technologies and pricing; disruption in research and development facilities; lawsuits and other claims by third parties or investigations by various regulatory agencies governing the Company’s operations; potential cybersecurity attacks; increased requirements and costs related to cybersecurity; the Company’s ability to realize the benefits of third party licensing agreements; the Company’s ability to obtain and maintain intellectual property protection for Ainos product candidates; compliance with applicable laws, regulations and tariffs; continued listing on and compliance with the applicable regulations of the Nasdaq Capital Market; and the Company’s success in managing growth. A more complete description of these risk factors and others is included in the “Risk Factors” section of Ainos’ Annual Report on Form 10-K for the year ended December 31, 2023 and other reports filed with the U.S. Securities and Exchange Commission (“SEC”), many of which risks are beyond the Company’s control. In addition to the risks described above and in the Company’s reports filed with the SEC, other unknown or unpredictable factors also could cause actual results to differ materially from the projections, forecasts, estimates and expectations discussed in this press release.

 

The forward-looking statements made in this press release are expressly qualified in their entirety by the foregoing cautionary statements. Any forward-looking statements contained in this press release represent Ainos’ views only as of today and should not be relied upon as representing its views as of any subsequent date. Ainos undertakes no obligation to, and expressly disclaims any such obligation to, publicly update or revise any forward-looking statement to reflect changed assumptions, the occurrence of anticipated or unanticipated events or changes to the future results over time or otherwise, except as required by law.

 

Investor Relations Contact

 

Feifei Shen

IR@ainos.com

 

 

 

 

Ainos, Inc.

Condensed Balance Sheets

(Unaudited)

 

   March 31,   December 31, 
   2024   2023 
Assets          
Current assets:          
Cash and cash equivalents  $1,030,899   $1,885,628 
Accounts receivable   4,172    455 
Inventory, net   169,655    167,593 
Other current asset   304,608    419,521 
Total current assets   1,509,334    2,473,197 
Intangible assets, net   27,155,594    28,283,208 
Property and equipment, net   768,665    876,572 
Other assets   320,867    208,827 
Total assets  $29,754,460   $31,841,804 
           
Liabilities and Stockholders’ Equity          
Current liabilities:          
Contract liabilities  $108,000   $112,555 
Convertible notes payable   3,000,000    - 
Other notes payable, related party   312,000    42,000 
Accrued expenses and others current liabilities   1,285,973    1,182,283 
Total current liabilities   4,705,973    1,336,838 
Senior secured convertible notes measured at fair value   2,369,694    2,651,556 
Convertible notes payable - noncurrent   -    3,000,000 
Other notes payable, related party - noncurrent   -    270,000 
Other long-term liabilities   -    135,829 
Total liabilities   7,075,667    7,394,223 
Commitments and contingencies          
Stockholders’ equity:          
Preferred stock, $0.01 par value; 50,000,000 shares authorized; none issued and outstanding   -    - 
Common stock, $0.01 par value; 300,000,000 shares authorized as of March 31, 2024 and December 31, 2023, 6,144,506 and 4,677,787 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively   61,445    46,778 
Common stock to be issued, 270 shares and 162,337 shares as of March 31, 2024 and December 31, 2023, respectively   3    1,623 
Additional paid-in capital   64,154,052    62,555,808 
Accumulated deficit   (41,200,965)   (37,886,155)
Accumulated other comprehensive loss - translation adjustment   (335,742)   (270,473)
Total stockholders’ equity   22,678,793    24,447,581 
Total liabilities and stockholders’ equity  $29,754,460   $31,841,804 

 

 

 

 

Ainos, Inc.

Condensed Statements of Operations

(Unaudited)

 

   Three months ended March 31, 
   2024   2023 
         
Revenues  $20,729   $49,164 
Cost of revenues   (26,754)   (100,848)
Gross loss   (6,025)   (51,684)
Operating expenses:          
  Research and development expenses   2,084,648    1,698,883 
  Selling, general and administrative expenses   1,029,418    762,465 
     Total operating expenses   3,114,066    2,461,348 
Loss from operations   (3,120,091)   (2,513,032)
           
Non-operating (expenses) income, net:          
Interest expense   (48,696)   (9,273)
Issuance cost of senior secured convertible note measured at fair value   (138,992)   - 
Fair value change for senior secured convertible note   (31,568)   - 
Other income, net   24,537    1,830 
     Total non-operating expenses, net   (194,719)   (7,443)
           
Net loss before income taxes   (3,314,810)   (2,520,475)
Provision for income taxes   -    - 
Net loss  $(3,314,810)  $(2,520,475)
Net loss per common share - basic and diluted  $(0.57)  $(0.63)
Weighted-average shares used in computing net loss per common share-basic and diluted   5,771,283    4,002,210 

 

 

 

 EX-101.SCH 3 aimd-20240513.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 4 aimd-20240513_def.xml XBRL DEFINITION FILE EX-101.LAB 5 aimd-20240513_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Stock, par value $0.01 per share Warrants to purchase Common Stock Statement [Table] Statement [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 aimd-20240513_pre.xml XBRL PRESENTATION FILE XML 8 R1.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Cover
May 13, 2024
Document Type 8-K
Amendment Flag false
Document Period End Date May 13, 2024
Entity File Number 001-41461
Entity Registrant Name AINOS, INC.
Entity Central Index Key 0001014763
Entity Tax Identification Number 75-1974352
Entity Incorporation, State or Country Code TX
Entity Address, Address Line One 8880 Rio San Diego Drive
Entity Address, Address Line Two Ste. 800
Entity Address, City or Town San Diego
Entity Address, State or Province CA
Entity Address, Postal Zip Code 92108
City Area Code (858)
Local Phone Number 869-2986
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity Emerging Growth Company false
Common Stock, par value $0.01 per share  
Title of 12(b) Security Common Stock, par value $0.01 per share
Trading Symbol AIMD
Security Exchange Name NASDAQ
Warrants to purchase Common Stock  
Title of 12(b) Security Warrants to purchase Common Stock
Trading Symbol AIMDW
Security Exchange Name NASDAQ
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1.1.u2 html 3 23 1 false 2 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://ainos.com/role/Cover Cover Cover 1 false false All Reports Book All Reports aimd-20240513.xsd aimd-20240513_def.xml aimd-20240513_lab.xml aimd-20240513_pre.xml form8-k.htm http://xbrl.sec.gov/dei/2024 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "AIMD", "nsuri": "http://ainos.com/20240513", "dts": { "schema": { "local": [ "aimd-20240513.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd", "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd", "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd", "https://xbrl.sec.gov/country/2024/country-2024.xsd", "https://xbrl.sec.gov/dei/2024/dei-2024.xsd", "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" ] }, "definitionLink": { "local": [ "aimd-20240513_def.xml" ] }, "labelLink": { "local": [ "aimd-20240513_lab.xml" ] }, "presentationLink": { "local": [ "aimd-20240513_pre.xml" ] }, "inline": { "local": [ "form8-k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 0, "memberCustom": 2, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2024": 2 }, "contextCount": 3, "entityCount": 1, "segmentCount": 2, "elementCount": 65, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2024": 26 }, "report": { "R1": { "role": "http://ainos.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-05-13", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-05-13", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentDescription", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AmendmentFlag", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AnnualInformationForm", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CityAreaCode", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "us-gaap_ClassOfStockDomain": { "xbrltype": "domainItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "ClassOfStockDomain", "presentation": [ "http://ainos.com/role/Cover" ], "auth_ref": [] }, "AIMD_CommonStockParValue0.01PerShareMember": { "xbrltype": "domainItemType", "nsuri": "http://ainos.com/20240513", "localname": "CommonStockParValue0.01PerShareMember", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Common Stock, par value $0.01 per share" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CountryRegion", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAccountingStandard", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentAnnualReport", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodEndDate", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentPeriodStartDate", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentQuarterlyReport", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentRegistrationStatement", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentShellCompanyReport", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentTransitionReport", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentType", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine1", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine2", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressAddressLine3", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCityOrTown", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressCountry", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCentralIndexKey", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityExTransitionPeriod", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFileNumber", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityFilerCategory", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPrimarySicNumber", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityRegistrantName", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityShellCompany", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntitySmallBusiness", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityVoluntaryFilers", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Extension", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "LocalPhoneNumber", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "NoTradingSymbolFlag", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "PreCommencementTenderOffer", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12bTitle", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "Security12gTitle", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityExchangeName", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SecurityReportingObligation", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "SolicitingMaterial", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "us-gaap_StatementClassOfStockAxis": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementClassOfStockAxis", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Class of Stock [Axis]" } } }, "auth_ref": [] }, "us-gaap_StatementLineItems": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementLineItems", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Line Items]" } } }, "auth_ref": [] }, "us-gaap_StatementTable": { "xbrltype": "stringItemType", "nsuri": "http://fasb.org/us-gaap/2024", "localname": "StatementTable", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Statement [Table]" } } }, "auth_ref": [] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "TradingSymbol", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "AIMD_WarrantsToPurchaseCommonStockMember": { "xbrltype": "domainItemType", "nsuri": "http://ainos.com/20240513", "localname": "WarrantsToPurchaseCommonStockMember", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Warrants to purchase Common Stock" } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2024", "localname": "WrittenCommunications", "presentation": [ "http://ainos.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14a", "Subsection": "12" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001493152-24-018884-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-018884-xbrl.zip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end XML 18 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001014763 2024-05-13 2024-05-13 0001014763 AIMD:CommonStockParValue0.01PerShareMember 2024-05-13 2024-05-13 0001014763 AIMD:WarrantsToPurchaseCommonStockMember 2024-05-13 2024-05-13 iso4217:USD shares iso4217:USD shares false 0001014763 8-K 2024-05-13 AINOS, INC. TX 001-41461 75-1974352 8880 Rio San Diego Drive Ste. 800 San Diego CA 92108 (858) 869-2986 false false false false Common Stock, par value $0.01 per share AIMD NASDAQ Warrants to purchase Common Stock AIMDW NASDAQ false